StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
HLS Therapeutics Inc.
Toronto Stock Exchange:HLS.TO
Sector
Location
Market Cap
USD 112.79 M
Share Price
USD 3.57
Avg Daily Volume
12,877
Change (1 day)
0.48%
Change (1 year)
40.99%
Change (YTD)
30.56%
HLS Therapeutics Inc. Share Price Year-To-Date (YTD) return on July 14, 2025: 30.56%
HLS Therapeutics Inc. Share Price Year-To-Date (YTD) return is 30.56% on July 14, 2025. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance. Year-to-Date (YTD) return is is the percentage change in the price of a stock from the start of the calendar year up to the current date, it shows how much the stock has gained or lost since the beginning of the year.
-
HLS Therapeutics Inc. 52-week low Share Price is USD 3.68 on July 14, 2025, which is 3.18% above the current Share Price.
-
HLS Therapeutics Inc. 52-week low Share Price is USD 2.18 on July 14, 2025, which is -38.76% below the current Share Price.
-
HLS Therapeutics Inc. average Share Price for the last 52 weeks is USD 2.84.
Competitors
Eli Lilly and Company
USD 799.34
LLY
+6.33
0.80%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%
GSK plc
USD 19.13
GSK.L
+0.13
0.71%
Chugai Pharmaceutical Co., Ltd.
USD 46.16
4519.T
-0.43
-0.92%
Regeneron Pharmaceuticals, Inc.
USD 570.59
REGN
+2.85
0.50%
Cencora, Inc.
USD 297.06
COR
+1.85
0.63%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.98
600276.SS
+0.04
0.52%
Takeda Pharmaceutical Company Limited
USD 29.87
4502.T
+0.36
1.22%
Haleon plc
USD 4.93
HLN.L
-0.02
-0.48%
Daiichi Sankyo Company, Limited
USD 23.02
4568.T
+0.44
1.93%
Ucb S.A.
USD 201.26
UCB.BR
+1.45
0.73%
BeOne Medicines Ltd.
USD 252.14
ONC
+1.84
0.73%
Key Data
| Date | Share Price Year-To-Date (YTD) return | Price to Earnings Ratio (P/E) | Price to Book Ratio (P/B) | Price to Sales Ratio (P/S) |
|---|
Competitors
Eli Lilly and Company
USD 799.34
LLY
+6.33
0.80%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%
GSK plc
USD 19.13
GSK.L
+0.13
0.71%
Chugai Pharmaceutical Co., Ltd.
USD 46.16
4519.T
-0.43
-0.92%
Regeneron Pharmaceuticals, Inc.
USD 570.59
REGN
+2.85
0.50%
Cencora, Inc.
USD 297.06
COR
+1.85
0.63%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.98
600276.SS
+0.04
0.52%
Takeda Pharmaceutical Company Limited
USD 29.87
4502.T
+0.36
1.22%
Haleon plc
USD 4.93
HLN.L
-0.02
-0.48%
Daiichi Sankyo Company, Limited
USD 23.02
4568.T
+0.44
1.93%
Ucb S.A.
USD 201.26
UCB.BR
+1.45
0.73%
BeOne Medicines Ltd.
USD 252.14
ONC
+1.84
0.73%